Pietrabissa Andrea, Ferrari Mauro, Berchiolli Raffaella, Morelli Luca, Pugliese Luigi, Ferrari Vincenzo, Mosca Franco
Divisione di Chirurgia I Universitaria, Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologie in Medicina, Università di Pisa, Pisa, Italy.
J Vasc Surg. 2009 Aug;50(2):275-9. doi: 10.1016/j.jvs.2009.03.015.
The purpose of this study was to report a series of 16 consecutive patients who underwent laparoscopic treatment of splenic artery aneurysms.
Over a period of 8 years, patients were selected for the laparoscopic option by a team of specialists that included the vascular surgeon, the interventional radiologist, and the laparoscopic surgeon. The mean size of the aneurysm was 32 mm and most was located at the splenic hilum. They were twice as common in females as in males. Ultrasonography with color Doppler function was used to define intraoperative strategy.
The laparoscopic treatment entailed excision of the aneurysm or its exclusion, usually reserved for distally located lesions. In one patient, laparoscopic resection and robotic anastomosis of the splenic artery was performed to re-establish flow to the spleen. In two patients, the intraoperative decision was added to combine a laparoscopic splenectomy due to insufficient residual arterial flow to the spleen. There was no conversion, or need for re-operation or related mortality. Analysis of intraoperative arterial flow data avoided unnecessary splenectomy following noncritical reduction of flow to the spleen.
The use of intraoperative color Doppler ultrasonography is essential in deciding the appropriate procedure and whether the spleen should be removed or saved. Early control of the splenic artery proximal to the aneurysm can limit the risk of conversion due to intraoperative bleeding. Distally located aneurysms are more difficult to manage and entail a higher risk of associated splenectomy. The laparoscopic option offers some advantages over the endovascular treatment in selected patients. A multidisciplinary approach is the key to a successful treatment of this uncommon disease.
本研究旨在报告连续16例接受腹腔镜治疗脾动脉瘤的患者。
在8年的时间里,由包括血管外科医生、介入放射科医生和腹腔镜外科医生在内的专家团队选择适合腹腔镜治疗的患者。动脉瘤的平均大小为32毫米,大多数位于脾门。女性患者的发病率是男性患者的两倍。使用具有彩色多普勒功能的超声来确定术中策略。
腹腔镜治疗包括切除动脉瘤或进行动脉瘤旷置术,后者通常用于治疗位于远端的病变。在1例患者中,进行了腹腔镜下脾动脉切除和机器人吻合术以重建脾脏血流。在2例患者中,由于脾脏残余动脉血流不足,术中决定联合进行腹腔镜脾切除术。没有出现中转开腹、再次手术或相关死亡情况。对术中动脉血流数据的分析避免了在脾脏血流非关键性减少后进行不必要的脾切除术。
术中使用彩色多普勒超声对于确定合适的手术方式以及是否保留脾脏至关重要。在动脉瘤近端早期控制脾动脉可降低术中出血导致中转开腹的风险。位于远端的动脉瘤更难处理,且脾切除相关风险更高。在部分患者中,腹腔镜治疗比血管内治疗具有一些优势。多学科方法是成功治疗这种罕见疾病的关键。